Improving prognosis in hepatorenal syndrome

Gut. 2000 Aug;47(2):166-7. doi: 10.1136/gut.47.2.166.
No abstract available

Publication types

  • Comment

MeSH terms

  • Hepatorenal Syndrome / therapy*
  • Humans
  • Portasystemic Shunt, Transjugular Intrahepatic
  • Prognosis
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Vasoconstrictor Agents